In-Space Drug Development Program Expands
New Redwire PIL-BOX Technology and Cancer-Detection Experiment Launched to ISS
A new drug development technology and a cancer-detection experiment has been launched to the International Space Station (ISS) as Redwire scales its in-space pharmaceutical drug development program based on the success of its PIL-BOX platform.
“Gold nanospheres could lead to early testing and diagnosis of cancer and other diseases, targeted drug delivery…
Keep reading with a 7-day free trial
Subscribe to The Journal of Space Commerce to keep reading this post and get 7 days of free access to the full post archives.